Results: 8
Safety and Effectiveness of COVID-19 Vaccines During Pregnancy: A Living Systematic Review and Meta-analysis.
- Published in:
- Drug Safety, 2024, v. 47, n. 10, p. 991, doi. 10.1007/s40264-024-01458-w
- By:
- Publication type:
- Article
The PrescIT platform: An interoperable Clinical Decision Support System for ePrescription to Prevent Adverse Drug Reactions and Drug-Drug Interactions.
- Published in:
- Drug Safety, 2024, v. 47, n. 10, p. 1051, doi. 10.1007/s40264-024-01455-z
- By:
- Publication type:
- Article
Pregnancy Outcomes in Patients Treated with Upadacitinib: Analysis of Data from Clinical Trials and Postmarketing Reports.
- Published in:
- Drug Safety, 2024, v. 47, n. 10, p. 1039, doi. 10.1007/s40264-024-01454-0
- By:
- Publication type:
- Article
The STAR Compass to Guide Future Pharmacovigilance Based on a 10-Year Review of the Strengthened EU System.
- Published in:
- Drug Safety, 2024, v. 47, n. 10, p. 941, doi. 10.1007/s40264-024-01451-3
- By:
- Publication type:
- Article
Real-World Effectiveness and Safety of Tixagevimab–Cilgavimab: A Target Trial Emulation Study.
- Published in:
- Drug Safety, 2024, v. 47, n. 10, p. 1025, doi. 10.1007/s40264-024-01450-4
- By:
- Publication type:
- Article
What is the Safety of COVID-19 Vaccines in Immunocompromised Patients? Results from the European "Covid Vaccine Monitor" Active Surveillance Study.
- Published in:
- Drug Safety, 2024, v. 47, n. 10, p. 1011, doi. 10.1007/s40264-024-01449-x
- By:
- Publication type:
- Article
Use of the Sentinel System to Examine Medical Product Use and Outcomes During Pregnancy.
- Published in:
- Drug Safety, 2024, v. 47, n. 10, p. 931, doi. 10.1007/s40264-024-01447-z
- By:
- Publication type:
- Article
Pharmacovigilance in Pregnancy Studies, Exposures and Outcomes Ascertainment, and Findings from Low- and Middle-Income Countries: A Scoping Review.
- Published in:
- Drug Safety, 2024, v. 47, n. 10, p. 957, doi. 10.1007/s40264-024-01445-1
- By:
- Publication type:
- Article